<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36746942</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca<sup>2+</sup> accumulation in spinobulbar muscular atrophy skeletal muscle.</ArticleTitle><Pagination><StartPage>602</StartPage><MedlinePgn>602</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">602</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-36185-w</ELocationID><Abstract><AbstractText>Polyglutamine expansion in the androgen receptor (AR) causes spinobulbar muscular atrophy (SBMA). Skeletal muscle is a primary site of toxicity; however, the current understanding of the early pathological processes that occur and how they unfold during disease progression remains limited. Using transgenic and knock-in mice and patient-derived muscle biopsies, we show that SBMA mice in the presymptomatic stage develop a respiratory defect matching defective expression of genes involved in excitation-contraction coupling (ECC), altered contraction dynamics, and increased fatigue. These processes are followed by stimulus-dependent accumulation of calcium into mitochondria and structural disorganization of the muscle triads. Deregulation of expression of ECC genes is concomitant with sexual maturity and androgen raise in the serum. Consistent with the androgen-dependent nature of these alterations, surgical castration and AR silencing alleviate the early and late pathological processes. These observations show that ECC deregulation and defective mitochondrial respiration are early but reversible events followed by altered muscle force, calcium dyshomeostasis, and dismantling of triad structure.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Marchioretti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), Padova, 35100, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), Padova, 35100, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dulbecco Telethon Institute (DTI) at the Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, 38123, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zanetti</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9350-1047</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pirazzini</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4127-254X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIR-Myo, Centro Interdipartimentale di Ricerca di Miologia, University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gherardi</LastName><ForeName>Gaia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogara</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), Padova, 35100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreotti</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), Padova, 35100, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), Padova, 35100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martini</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0146-1031</Identifier><AffiliationInfo><Affiliation>Department of Molecular and Translational Medicine, University of Brescia, 25121, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcucci</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9542-4417</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canato</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Samir R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuccaro</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), Padova, 35100, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), Padova, 35100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chivet</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dulbecco Telethon Institute (DTI) at the Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, 38123, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mammucari</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIR-Myo, Centro Interdipartimentale di Ricerca di Miologia, University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacifici</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raffaello</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIR-Myo, Centro Interdipartimentale di Ricerca di Miologia, University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzuto</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattarei</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2023-0749</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desbats</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Clinical Genetics Unit, Department of Women and Children's Health, University of Padova, and Fondazione Istituto di Ricerca Pediatrica Citt&#xe0; della Speranza, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salviati</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5642-9963</Identifier><AffiliationInfo><Affiliation>CIR-Myo, Centro Interdipartimentale di Ricerca di Miologia, University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Genetics Unit, Department of Women and Children's Health, University of Padova, and Fondazione Istituto di Ricerca Pediatrica Citt&#xe0; della Speranza, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Megighian</LastName><ForeName>Aram</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7971-5310</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), Padova, 35100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorar&#xf9;</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), Padova, 35100, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience (DNS), University of Padova, 35128, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pegoraro</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7740-4156</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience (DNS), University of Padova, 35128, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belluzzi</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1129-2574</Identifier><AffiliationInfo><Affiliation>Orthopedics and Orthopedic Oncology, Department of Surgery, Oncology, and Gastroenterology DiSCOG, University-Hospital of Padova, 35128, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Musculoskeletal Pathology and Oncology Laboratory, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padova, 35128, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pozzuoli</LastName><ForeName>Assunta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Orthopedics and Orthopedic Oncology, Department of Surgery, Oncology, and Gastroenterology DiSCOG, University-Hospital of Padova, 35128, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Musculoskeletal Pathology and Oncology Laboratory, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padova, 35128, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biz</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Orthopedics and Orthopedic Oncology, Department of Surgery, Oncology, and Gastroenterology DiSCOG, University-Hospital of Padova, 35128, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruggieri</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9617-9882</Identifier><AffiliationInfo><Affiliation>Orthopedics and Orthopedic Oncology, Department of Surgery, Oncology, and Gastroenterology DiSCOG, University-Hospital of Padova, 35128, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romualdi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4792-9047</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Padova, Padova, 35100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Gopal J</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0001-7833-5300</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology and Molecular Medicine, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandri</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8509-7558</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), Padova, 35100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaauw</LastName><ForeName>Bert</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), Padova, 35100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basso</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9278-8960</Identifier><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, 38123, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennuto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8634-0767</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy. maria.pennuto@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), Padova, 35100, Italy. maria.pennuto@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), Padova, 35100, Italy. maria.pennuto@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dulbecco Telethon Institute (DTI) at the Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, 38123, Trento, Italy. maria.pennuto@unipd.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS119873</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR069107</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS055746</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000728">Androgens</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000728" MajorTopicYN="Y">Androgens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012119" MajorTopicYN="N">Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36746942</ArticleId><ArticleId IdType="pmc">PMC9902403</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-36185-w</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-36185-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77&#x2013;79. doi: 10.1038/352077a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671&#x2013;680. doi: 10.1212/WNL.18.7.671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.18.7.671</ArticleId><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennuto M, Rinaldi C. From gene to therapy in spinal and bulbar muscular atrophy: are we there yet? Mol. Cell Endocrinol. 2018;465:113&#x2013;121. doi: 10.1016/j.mce.2017.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2017.07.005</ArticleId><ArticleId IdType="pubmed">28688959</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen ES, et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci. 2004;24:4778&#x2013;4786. doi: 10.1523/JNEUROSCI.0808-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0808-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Chivet, M. et al. Polyglutamine-expanded androgen receptor alteration of skeletal muscle homeostasis and myonuclear aggregation are affected by sex, age and muscle metabolism. Cells9, cells9020325. 10.3390/cells9020325 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7072234</ArticleId><ArticleId IdType="pubmed">32019272</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35:843&#x2013;854. doi: 10.1016/S0896-6273(02)00834-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00834-6</ArticleId><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, et al. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Investig. 2006;116:2663&#x2013;2672. doi: 10.1172/JCI28773..</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI28773.</ArticleId><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano R, et al. Beyond motor neurons: expanding the clinical spectrum in Kennedy&#x2019;s disease. J. Neurol. Neurosurg. Psychiatry. 2018;89:808&#x2013;812. doi: 10.1136/jnnp-2017-316961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316961</ArticleId><ArticleId IdType="pmc">PMC6204939</ArticleId><ArticleId IdType="pubmed">29353237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambataro F, Pennuto M. Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases. Prog. Neurobiol. 2012;97:152&#x2013;172. doi: 10.1016/j.pneurobio.2011.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.10.003</ArticleId><ArticleId IdType="pubmed">22061202</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchioretti, C. et al. Skeletal muscle pathogenesis in polyglutamine diseases. Cells11, 10.3390/cells11132105 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9265456</ArticleId><ArticleId IdType="pubmed">35805189</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgia D, et al. Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients. Hum. Mol. Genet. 2017;26:1087&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409076</ArticleId><ArticleId IdType="pubmed">28087734</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahin N, Sorenson EJ. Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Muscle Nerve. 2009;40:126&#x2013;129. doi: 10.1002/mus.21310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21310</ArticleId><ArticleId IdType="pubmed">19533663</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding AE, et al. X-linked recessive bulbospinal neuronopathy: a report of ten cases. J. Neurol. Neurosurg. Psychiatry. 1982;45:1012&#x2013;1019. doi: 10.1136/jnnp.45.11.1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.45.11.1012</ArticleId><ArticleId IdType="pmc">PMC491638</ArticleId><ArticleId IdType="pubmed">6890989</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraru G, et al. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J. Neurol. Sci. 2008;264:100&#x2013;105. doi: 10.1016/j.jns.2007.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.08.012</ArticleId><ArticleId IdType="pubmed">17854832</ArticleId></ArticleIdList></Reference><Reference><Citation>Oki K, et al. Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy. J. Appl. Physiol. 2015;118:941&#x2013;952. doi: 10.1152/japplphysiol.00886.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00886.2014</ArticleId><ArticleId IdType="pmc">PMC4385878</ArticleId><ArticleId IdType="pubmed">25663674</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, et al. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc. Natl Acad. Sci. USA. 2007;104:18259&#x2013;18264. doi: 10.1073/pnas.0705501104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0705501104</ArticleId><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron. 2014;82:295&#x2013;307. doi: 10.1016/j.neuron.2014.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.03.001</ArticleId><ArticleId IdType="pmc">PMC4096235</ArticleId><ArticleId IdType="pubmed">24742458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi, V. et al. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy. Neurology. 10.1212/WNL.0000000000007097 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6511101</ArticleId><ArticleId IdType="pubmed">30787165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 2014;7:774&#x2013;784. doi: 10.1016/j.celrep.2014.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.02.008</ArticleId><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Milioto C, et al. Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes. Sci. Rep. 2017;7:41046. doi: 10.1038/srep41046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41046</ArticleId><ArticleId IdType="pmc">PMC5259768</ArticleId><ArticleId IdType="pubmed">28117338</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I, et al. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron. 2009;63:316&#x2013;328. doi: 10.1016/j.neuron.2009.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.07.019</ArticleId><ArticleId IdType="pmc">PMC2735765</ArticleId><ArticleId IdType="pubmed">19679072</ArticleId></ArticleIdList></Reference><Reference><Citation>Gissel H. The role of Ca2+ in muscle cell damage. Ann. N. Y. Acad. Sci. 2005;1066:166&#x2013;180. doi: 10.1196/annals.1363.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1363.013</ArticleId><ArticleId IdType="pubmed">16533926</ArticleId></ArticleIdList></Reference><Reference><Citation>Primeau JO, Armanious GP, Fisher ME, Young HS. The SarcoEndoplasmic reticulum calcium ATPase. Subcell. Biochem. 2018;87:229&#x2013;258. doi: 10.1007/978-981-10-7757-9_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-10-7757-9_8</ArticleId><ArticleId IdType="pubmed">29464562</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol. Rev. 1990;70:391&#x2013;425. doi: 10.1152/physrev.1990.70.2.391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1990.70.2.391</ArticleId><ArticleId IdType="pubmed">2157230</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgi C, Marchi S, Pinton P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat. Rev. Mol. Cell Biol. 2018;19:713&#x2013;730. doi: 10.1038/s41580-018-0052-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0052-8</ArticleId><ArticleId IdType="pubmed">30143745</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi A, et al. Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathol. 2016;132:127&#x2013;144. doi: 10.1007/s00401-016-1550-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1550-4</ArticleId><ArticleId IdType="pmc">PMC4911374</ArticleId><ArticleId IdType="pubmed">26971100</ArticleId></ArticleIdList></Reference><Reference><Citation>Gegenhuber B, Tollkuhn J. Signatures of sex: sex differences in gene expression in the vertebrate brain. Wiley Interdiscip. Rev. Dev. Biol. 2020;9:e348. doi: 10.1002/wdev.348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wdev.348</ArticleId><ArticleId IdType="pmc">PMC6864223</ArticleId><ArticleId IdType="pubmed">31106965</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K, et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain. 2008;131:229&#x2013;239. doi: 10.1093/brain/awm289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm289</ArticleId><ArticleId IdType="pubmed">18056738</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, et al. Defects in neuromuscular transmission may underlie motor dysfunction in spinal and bulbar muscular atrophy. J. Neurosci. 2016;36:5094&#x2013;5106. doi: 10.1523/JNEUROSCI.3485-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3485-15.2016</ArticleId><ArticleId IdType="pmc">PMC4854970</ArticleId><ArticleId IdType="pubmed">27147661</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlqvist JR, et al. Muscle contractility in spinobulbar muscular atrophy. Sci. Rep. 2019;9:4680. doi: 10.1038/s41598-019-41240-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41240-y</ArticleId><ArticleId IdType="pmc">PMC6423126</ArticleId><ArticleId IdType="pubmed">30886222</ArticleId></ArticleIdList></Reference><Reference><Citation>Oki K, Wiseman RW, Breedlove SM, Jordan CL. Androgen receptors in muscle fibers induce rapid loss of force but not mass: implications for spinal bulbar muscular atrophy. Muscle Nerve. 2013;47:823&#x2013;834. doi: 10.1002/mus.23813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23813</ArticleId><ArticleId IdType="pmc">PMC4015727</ArticleId><ArticleId IdType="pubmed">23629944</ArticleId></ArticleIdList></Reference><Reference><Citation>Polanco MJ, et al. Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. Sci. Transl. Med. 2016;8:370ra181. doi: 10.1126/scitranslmed.aaf9526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf9526</ArticleId><ArticleId IdType="pubmed">28003546</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P, et al. Aberrant autophagic response in the muscle of a knock-in mouse model of spinal and bulbar muscular atrophy. Sci. Rep. 2015;5:15174. doi: 10.1038/srep15174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15174</ArticleId><ArticleId IdType="pmc">PMC4614888</ArticleId><ArticleId IdType="pubmed">26490709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath SR, et al. MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease. Acta Neuropathol. 2020;140:63&#x2013;80. doi: 10.1007/s00401-020-02156-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02156-4</ArticleId><ArticleId IdType="pmc">PMC7166004</ArticleId><ArticleId IdType="pubmed">32306066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Dhakal K, Yi J. Mitochondrial Ca(2+) uptake in skeletal muscle health and disease. Sci. China Life Sci. 2016;59:770&#x2013;776. doi: 10.1007/s11427-016-5089-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-016-5089-3</ArticleId><ArticleId IdType="pmc">PMC6168075</ArticleId><ArticleId IdType="pubmed">27430885</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendin D, et al. A Synthetic Fluorescent Mitochondria-Targeted Sensor for Ratiometric Imaging of Calcium in Live Cells. Angew. Chem. Int Ed. Engl. 2019;58:9917&#x2013;9922. doi: 10.1002/anie.201902272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201902272</ArticleId><ArticleId IdType="pubmed">31132197</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Rhodes LE, et al. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol. 2011;10:140&#x2013;147. doi: 10.1016/S1474-4422(10)70321-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70321-5</ArticleId><ArticleId IdType="pmc">PMC3056353</ArticleId><ArticleId IdType="pubmed">21216197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume A, et al. Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials. J. Neurol. 2019;266:1211&#x2013;1221. doi: 10.1007/s00415-019-09251-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09251-x</ArticleId><ArticleId IdType="pubmed">30847645</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgetti E, et al. Rescue of metabolic alterations in AR113Q skeletal muscle by peripheral androgen receptor gene silencing. Cell Rep. 2016;17:125&#x2013;136. doi: 10.1016/j.celrep.2016.08.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.08.084</ArticleId><ArticleId IdType="pmc">PMC5076565</ArticleId><ArticleId IdType="pubmed">27681426</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowling JJ, Lawlor MW, Dirksen RT. Triadopathies: an emerging class of skeletal muscle diseases. Neurotherapeutics. 2014;11:773&#x2013;785. doi: 10.1007/s13311-014-0300-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-014-0300-3</ArticleId><ArticleId IdType="pmc">PMC4391390</ArticleId><ArticleId IdType="pubmed">25168790</ArticleId></ArticleIdList></Reference><Reference><Citation>Marty I, Faure J. Excitation-contraction coupling alterations in myopathies. J. Neuromuscul. Dis. 2016;3:443&#x2013;453. doi: 10.3233/JND-160172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-160172</ArticleId><ArticleId IdType="pmc">PMC5240595</ArticleId><ArticleId IdType="pubmed">27911331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. A mutation in the human ryanodine receptor gene associated with central core disease. Nat. Genet. 1993;5:46&#x2013;50. doi: 10.1038/ng0993-46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0993-46</ArticleId><ArticleId IdType="pubmed">8220422</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii J, et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science. 1991;253:448&#x2013;451. doi: 10.1126/science.1862346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1862346</ArticleId><ArticleId IdType="pubmed">1862346</ArticleId></ArticleIdList></Reference><Reference><Citation>Boncompagni S, et al. Characterization and temporal development of cores in a mouse model of malignant hyperthermia. Proc. Natl Acad. Sci. USA. 2009;106:21996&#x2013;22001. doi: 10.1073/pnas.0911496106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911496106</ArticleId><ArticleId IdType="pmc">PMC2799858</ArticleId><ArticleId IdType="pubmed">19966218</ArticleId></ArticleIdList></Reference><Reference><Citation>Delbono O, O&#x2019;Rourke KS, Ettinger WH. Excitation-calcium release uncoupling in aged single human skeletal muscle fibers. J. Membr. Biol. 1995;148:211&#x2013;222. doi: 10.1007/BF00235039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00235039</ArticleId><ArticleId IdType="pubmed">8747553</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson DC, et al. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 2011;14:196&#x2013;207. doi: 10.1016/j.cmet.2011.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.05.014</ArticleId><ArticleId IdType="pmc">PMC3690519</ArticleId><ArticleId IdType="pubmed">21803290</ArticleId></ArticleIdList></Reference><Reference><Citation>Periasamy M, Kalyanasundaram A. SERCA pump isoforms: Their role in calcium transport and disease. Muscle Nerve. 2007;35:430&#x2013;442. doi: 10.1002/mus.20745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20745</ArticleId><ArticleId IdType="pubmed">17286271</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki K, et al. Myotonia-like symptoms in a patient with spinal and bulbar muscular atrophy. Neuromuscul. Disord. 2015;25:913&#x2013;915. doi: 10.1016/j.nmd.2015.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2015.08.006</ArticleId><ArticleId IdType="pubmed">26363965</ArticleId></ArticleIdList></Reference><Reference><Citation>Tupling AR, Asahi M, MacLennan DH. Sarcolipin overexpression in rat slow twitch muscle inhibits sarcoplasmic reticulum Ca2+ uptake and impairs contractile function. J. Biol. Chem. 2002;277:44740&#x2013;44746. doi: 10.1074/jbc.M206171200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M206171200</ArticleId><ArticleId IdType="pubmed">12237298</ArticleId></ArticleIdList></Reference><Reference><Citation>Tupling AR, et al. Enhanced Ca2+ transport and muscle relaxation in skeletal muscle from sarcolipin-null mice. Am. J. Physiol. Cell Physiol. 2011;301:C841&#x2013;C849. doi: 10.1152/ajpcell.00409.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00409.2010</ArticleId><ArticleId IdType="pmc">PMC3654932</ArticleId><ArticleId IdType="pubmed">21697544</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider JS, et al. Increased sarcolipin expression and decreased sarco(endo)plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy. J. Muscle Res Cell Motil. 2013;34:349&#x2013;356. doi: 10.1007/s10974-013-9350-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10974-013-9350-0</ArticleId><ArticleId IdType="pubmed">23748997</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanaro S, et al. Gene expression profiling in dysferlinopathies using a dedicated muscle microarray. Hum. Mol. Genet. 2002;11:3283&#x2013;3298. doi: 10.1093/hmg/11.26.3283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.26.3283</ArticleId><ArticleId IdType="pubmed">12471055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottenheijm CAC, et al. Sarcoplasmic reticulum calcium uptake and speed of relaxation are depressed in nebulin-free skeletal muscle. FASEB J. 2008;22:2912&#x2013;2919. doi: 10.1096/fj.07-104372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.07-104372</ArticleId><ArticleId IdType="pmc">PMC2493448</ArticleId><ArticleId IdType="pubmed">18434434</ArticleId></ArticleIdList></Reference><Reference><Citation>Voit A, et al. Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice. Nat. Commun. 2017;8:1068. doi: 10.1038/s41467-017-01146-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01146-7</ArticleId><ArticleId IdType="pmc">PMC5648780</ArticleId><ArticleId IdType="pubmed">29051551</ArticleId></ArticleIdList></Reference><Reference><Citation>Semplicini C, et al. The clinical spectrum of CASQ1-related myopathy. Neurology. 2018;91:e1629&#x2013;e1641. doi: 10.1212/WNL.0000000000006387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006387</ArticleId><ArticleId IdType="pmc">PMC6205688</ArticleId><ArticleId IdType="pubmed">30258016</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuhlfauth I, Reininghaus J, Jockusch H, Heizmann CW. Calcium-binding protein, parvalbumin, is reduced in mutant mammalian muscle with abnormal contractile properties. Proc. Natl Acad. Sci. USA. 1984;81:4814&#x2013;4818. doi: 10.1073/pnas.81.15.4814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.81.15.4814</ArticleId><ArticleId IdType="pmc">PMC391581</ArticleId><ArticleId IdType="pubmed">6589628</ArticleId></ArticleIdList></Reference><Reference><Citation>Canato M, et al. Massive alterations of sarcoplasmic reticulum free calcium in skeletal muscle fibers lacking calsequestrin revealed by a genetically encoded probe. Proc. Natl Acad. Sci. USA. 2010;107:22326&#x2013;22331. doi: 10.1073/pnas.1009168108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1009168108</ArticleId><ArticleId IdType="pmc">PMC3009789</ArticleId><ArticleId IdType="pubmed">21135222</ArticleId></ArticleIdList></Reference><Reference><Citation>Dainese M, et al. Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice. FASEB J. 2009;23:1710&#x2013;1720. doi: 10.1096/fj.08-121335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.08-121335</ArticleId><ArticleId IdType="pmc">PMC2698659</ArticleId><ArticleId IdType="pubmed">19237502</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelucci A, Boncompagni S, Canato M, Reggiani C, Protasi F. Estrogens protect calsequestrin-1 knockout mice from lethal hyperthermic episodes by reducing oxidative stress in muscle. Oxid. Med Cell Longev. 2017;2017:6936897. doi: 10.1155/2017/6936897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/6936897</ArticleId><ArticleId IdType="pmc">PMC5610815</ArticleId><ArticleId IdType="pubmed">29062464</ArticleId></ArticleIdList></Reference><Reference><Citation>Racay P, Gregory P, Schwaller B. Parvalbumin deficiency in fast-twitch muscles leads to increased &#x2018;slow-twitch type&#x2019; mitochondria, but does not affect the expression of fiber specific proteins. FEBS J. 2006;273:96&#x2013;108. doi: 10.1111/j.1742-4658.2005.05046.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2005.05046.x</ArticleId><ArticleId IdType="pubmed">16367751</ArticleId></ArticleIdList></Reference><Reference><Citation>Butera G, et al. Parvalbumin affects skeletal muscle trophism through modulation of mitochondrial calcium uptake. Cell Rep. 2021;35:109087. doi: 10.1016/j.celrep.2021.109087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109087</ArticleId><ArticleId IdType="pmc">PMC8113653</ArticleId><ArticleId IdType="pubmed">33951435</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, et al. Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial. Lancet Neurol. 2018;17:1043&#x2013;1052. doi: 10.1016/S1474-4422(18)30320-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30320-X</ArticleId><ArticleId IdType="pmc">PMC6415539</ArticleId><ArticleId IdType="pubmed">30337273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamano T, et al. Muscle MRI findings of X-linked spinal and bulbar muscular atrophy. J. Neurol. Sci. 2004;222:93&#x2013;97. doi: 10.1016/j.jns.2004.04.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2004.04.028</ArticleId><ArticleId IdType="pubmed">15240202</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson EJ, Klein CJ. Elevated creatine kinase and transaminases in asymptomatic SBMA. Amyotroph. Lateral Scler. 2007;8:62&#x2013;64. doi: 10.1080/17482960600765040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600765040</ArticleId><ArticleId IdType="pubmed">17364438</ArticleId></ArticleIdList></Reference><Reference><Citation>Baughman JM, et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature. 2011;476:341&#x2013;345. doi: 10.1038/nature10234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10234</ArticleId><ArticleId IdType="pmc">PMC3486726</ArticleId><ArticleId IdType="pubmed">21685886</ArticleId></ArticleIdList></Reference><Reference><Citation>De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature. 2011;476:336&#x2013;340. doi: 10.1038/nature10230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10230</ArticleId><ArticleId IdType="pmc">PMC4141877</ArticleId><ArticleId IdType="pubmed">21685888</ArticleId></ArticleIdList></Reference><Reference><Citation>Das AM, Harris DA. Control of mitochondrial ATP synthase in heart cells: inactive to active transitions caused by beating or positive inotropic agents. Cardiovasc. Res. 1990;24:411&#x2013;417. doi: 10.1093/cvr/24.5.411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/24.5.411</ArticleId><ArticleId IdType="pubmed">1695547</ArticleId></ArticleIdList></Reference><Reference><Citation>Mildaziene V, et al. Calcium indirectly increases the control exerted by the adenine nucleotide translocator over 2-oxoglutarate oxidation in rat heart mitochondria. Arch. Biochem. Biophys. 1995;324:130&#x2013;134. doi: 10.1006/abbi.1995.9918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.1995.9918</ArticleId><ArticleId IdType="pubmed">7503547</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardi P, von Stockum S. The permeability transition pore as a Ca(2+) release channel: new answers to an old question. Cell Calcium. 2012;52:22&#x2013;27. doi: 10.1016/j.ceca.2012.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2012.03.004</ArticleId><ArticleId IdType="pmc">PMC3396848</ArticleId><ArticleId IdType="pubmed">22513364</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasi M, et al. Calsequestrin (CASQ1) rescues function and structure of calcium release units in skeletal muscles of CASQ1-null mice. Am. J. Physiol. Cell Physiol. 2012;302:C575&#x2013;C586. doi: 10.1152/ajpcell.00119.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00119.2011</ArticleId><ArticleId IdType="pubmed">22049211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieters, F., Gruhn, M., Buschges, A., Fink, G. R. &amp; Aswendt, M. Terminal H-reflex Measurements in Mice. J. Vis. Exp. 10.3791/63304 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35781283</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>